��㣨Leyu�� global tech report: Life sciences insights

123 healthcare technology function leaders

26 key markets

Majority of organisations with revenues of US$10B-plus

Globally, the life sciences sector is working on improving operations and creating new value by transforming digitally. In a highly regulated sector where companies are often fragmented and siloed, transforming at scale can be difficult. For these reasons, it can be helpful for tech function leaders to compare their decision making against their peers in the sector and other industries.

The ��㣨Leyu�� global tech report: Life sciences insights examines the views of senior-level life sciences technology function leaders from around the world that include chief digital officers, CIOs, CTOs, CISOs, chief AI officers and others. This report contains valuable insights into how life sciences organisations are navigating the complexities of digital transformation and covers topics that include technology investment decision making, data, AI and cyber security.

Many companies in the life science sector are embracing Digital transformation to accelerate innovation and bring products to market faster. However, transformation initiatives come at a cost and organisations are increasingly mindful of their impact on margins. A key insight is that a siloed and fragmented approach to transformation often results in higher costs and inefficiencies. This report provides guidance to help companies make more strategic and cohesive investments in critical areas such as data, Ai and cyber security ultimately enabling more effective and sustainable digital transformation.

Vijay Chawla

Partner and Head �� Life sciences, ��㣨Leyu�� in India

��㣨Leyu�� global tech report: Life sciences insights

��

Beyond the hype: Balancing speed, security and value

��㣨Leyu�� Global tech report: Life sciences insights pdf cover

Key findings from the research

work

Only 59 percent of life sciences respondents say their tech investment decision-making processes usually result in sound decisions that lead to valuable outcomes.

computer

Life sciences leads all of the eight industries surveyed in prioritising and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery.

smart_toy

More than one-third of life sciences respondents say their organisations are using AI at scale and are achieving returns on investment.

add_moderator

61 percent of life sciences respondents worry that cyber security is frequently treated as a box-ticking exercise in staff training and isn’t embedded as extensively as it could be.

Read the full report to explore more insights and ��㣨Leyu�� life sciences technology specialist perspectives on the findings, and to obtain actionable recommendations for addressing life sciences organisation technology challenges.

Methodology

The insights in this report were derived from the ��㣨Leyu�� global tech report 2024, a survey of 2,450 technology leaders from 26 countries across 8 industries: financial services, technology, retail and consumer packaged goods, industrial manufacturing, life sciences, healthcare, government and public sector, and energy. Survey respondents represented organisations with annual operating budgets or revenues above US$100M-plus.

Life sciences respondent demographics: 123 life sciences technology function leaders were surveyed of which a significant portion (85 percent) held C-suite or department head, EVP, SVP or VP level positions. A strong majority (86 percent) of these respondents represented life sciences organisations with revenues of US$10B to US$50B-plus.